VBIV - VBI Vaccines Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue8655489552,868
Cost of Revenue5,1933,6713,7533,699
Gross Profit-4,328-3,123-2,798-831
Operating Expenses
Research Development20,6189,966618634
Selling General and Administrative12,0349,2404,7112,728
Non Recurring----
Total Operating Expenses37,84522,8779,0827,061
Operating Income or Loss-36,980-22,329-8,127-4,193
Income from Continuing Operations
Total Other Income/Expenses Net-2,446-2,656-18,195-2,598
Earnings Before Interest and Taxes-36,980-22,329-8,127-4,193
Interest Expense-3,031-392-1,128-941
Income Before Tax-39,426-24,985-26,322-6,791
Income Tax Expense-431-1,780-129-1,119
Minority Interest----
Net Income From Continuing Ops-38,995-23,205-26,193-5,672
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-38,995-23,205-26,193-5,672
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-38,995-23,205-26,193-5,672